Loading...
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
BACKGROUND: Pancreatic cancer (PC) patients have multiple risk factors for sarcopenia and loss of skeletal muscle mass (LSMM), which may cause greater treatment toxicities, reduced response to cancer therapy, prolonged hospitalization, impaired quality of life, and worse prognosis. METHODS: This is...
Saved in:
Published in: | J Cachexia Sarcopenia Muscle |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
John Wiley and Sons Inc.
2019
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463465/ https://ncbi.nlm.nih.gov/pubmed/30719874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12368 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|